Client Login

In the News

Wednesday, February 14, 2018

Teva Exits Philly Reglan Mass Tort With Settlement

Teva settlement affects roughly 1,700 cases pending in the Reglan mass tort program in the Philadelphia.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, February 7, 2018

4th Circ. Upholds $18.5M Boston Scientific Mesh Verdict

Fourth Circuit rejected Boston Scientific's appeal of an $18.5 million verdict in a trial over injuries allegedly caused by its pelvic mesh devices.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, January 3, 2018

Auxilium Settles 1st Philly Testosterone Case

Auxilium Pharmaceuticals Inc. avoids an trial over the alleged connection between its testosterone gel and a user's stroke.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Thursday, December 14, 2017

Johnson & Johnson Ethicon Unit Hit With $15M Pelvic Mesh Verdict In NJ

After a three week trial, NJ jury hands down $15M verdict in favor of plaintiff over claims J&J lied about the safety of pelvic mesh product.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, November 20, 2017

Johnson & Johnson Hit with $247 Million Verdict in Hip Implant Trial

A federal jury in Dallas ordered Johnson & Johnson to pay $247 million to six patients who were injured by defective Pinnacle hip implants.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, October 18, 2017

Congress Allied with Drug Company Lobbyists to Derail the DEA’s War on Opioids

Amid a targeted lobbying effort, Congress weakened the DEA’s ability to go after drug distributors, even as opioid-related deaths continue to rise.

 

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, September 27, 2017

FDA Safety Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants

New FDA safety information shows the complications of treating addicted individuals.

 

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, September 27, 2017

Nearly Half Of Patients Who Stop Taking Opioids For Six Months Resume Use Later

According to researchers at Magellan Health in Scottsdale, over 50 percent of patients who quit opioids for six months will resume use sometime thereafter.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, September 11, 2017

Galena To Pay $7.5M To Settle Opioid Kickback Suit

Galena Biopharma Inc. has agreed to pay $7.55 million to settle allegations that it paid doctors kickbacks in exchange for prescribing its fentanyl-based drug Abstral,

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, September 11, 2017

F.D.A. Accuses EpiPen Maker of Failing to Investigate Malfunctions

EpiPen maker failed to investigate product flaws associated with patient deaths, FDA says

Author: Amy Schwarz
0 Comments
Article rating: No rating
RSS
123456